Columbia Financial (CLBK)
(Delayed Data from NSDQ)
$16.84 USD
-0.05 (-0.30%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $16.81 -0.03 (-0.18%) 6:16 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.84 USD
-0.05 (-0.30%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $16.81 -0.03 (-0.18%) 6:16 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Zacks News
Columbia Financial (CLBK) Meets Q3 Earnings Estimates
by Zacks Equity Research
Columbia Financial (CLBK) delivered earnings and revenue surprises of 0% and 0.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Jefferies (JEF) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Jefferies (JEF) delivered earnings and revenue surprises of 59.42% and 16.43%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Columbia Financial (CLBK) Meets Q2 Earnings Estimates
by Zacks Equity Research
Columbia Financial (CLBK) delivered earnings and revenue surprises of 0% and 2.66%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Royalty Pharma (RPRX) Surges 5.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Royalty Pharma (RPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Has Columbia Financial (CLBK) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Columbia Financial (CLBK) and CTO Realty (CTO) have performed compared to their sector so far this year.
Earnings Estimates Moving Higher for Columbia Financial (CLBK): Time to Buy?
by Zacks Equity Research
Columbia Financial (CLBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
PRA Group (PRAA) Down 6.8% Since Q1 Earnings Beat: Here's Why
by Zacks Equity Research
PRA Group (PRAA) expects the sales volume to increase by 2022 end, which will boost its quarterly performances.
MoneyGram (MGI) Down 3.1% Since Q1 Earnings & Sales Miss
by Zacks Equity Research
MoneyGram International's (MGI) Money Transfer business continues to perform well on the back of its rising cross-border transactions.
After Plunging 10.5% in 4 Weeks, Here's Why the Trend Might Reverse for Columbia Financial (CLBK)
by Zacks Equity Research
Columbia Financial (CLBK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Down 9.2% in 4 Weeks, Here's Why Columbia Financial (CLBK) Looks Ripe for a Turnaround
by Zacks Equity Research
Columbia Financial (CLBK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Columbia Financial (CLBK) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Columbia Financial (CLBK) delivered earnings and revenue surprises of 10% and 0.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Momentum in Columbia Financial (CLBK) Should Keep going
by Zacks Equity Research
Columbia Financial (CLBK) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
What Makes Columbia Financial (CLBK) a New Strong Buy Stock
by Zacks Equity Research
Columbia Financial (CLBK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why Should You Hold Owl Rock Capital (ORCC) in Your Portfolio?
by Zacks Equity Research
Banking on a robust portfolio and strategic measures, Owl Rock Capital (ORCC) holds the potential to reap benefits for investors.
Here's Why "Trend" Investors Would Love Betting on Columbia Financial (CLBK)
by Zacks Equity Research
Columbia Financial (CLBK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Why Columbia Financial (CLBK) Might be Well Poised for a Surge
by Zacks Equity Research
Columbia Financial (CLBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes Columbia Financial (CLBK) a Good Fit for "Trend Investing"
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Columbia Financial (CLBK) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Recent Price Trend in Columbia Financial (CLBK) is Your Friend, Here's Why
by Zacks Equity Research
Columbia Financial (CLBK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Columbia Financial (CLBK) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Columbia Financial (CLBK) delivered earnings and revenue surprises of 25% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Columbia Financial (CLBK) to Report Q4 Results: What Awaits?
by Zacks Equity Research
Columbia Financial (CLBK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KKR Rewards Shareholders With Expanded Share Buyback Program
by Zacks Equity Research
KKR's announcement of an expanded share repurchase program reflects its ability to enhance shareholder value.
New Mountain Finance (NMFC) Extends Share Buyback, Stock Up
by Zacks Equity Research
The announcement of an extended share repurchase program reflects New Mountain Finance's (NMFC) ability to augment shareholder value.
Banner (BANR) Rewards Investors With Buyback Plan, Stock Up
by Zacks Equity Research
Banner's (BANR) new share buyback program, along with regular dividend payouts, will continue to enhance shareholder value.
Victory Capital (VCTR) Stock Rises on New Share Repurchase Plan
by Zacks Equity Research
Victory Capital's (VCTR) new $15-million share buyback program along with inorganic expansion efforts will continue to drive shareholder value.
Cadence Bank's (CADE) Shares Rise on New Share Buyback Plan
by Zacks Equity Research
Cadence Bank's (CADE) new share buyback program along with dividend hikes will continue to boost shareholder confidence in the stock.